Biotechnology in China
Summary
Biotechnology in China industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The Chinese biotechnology market recorded revenues of $132.2 billion in 2024, representing a compound annual growth rate (CAGR) of 11.1% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $73.3 billion, equivalent to 55.4% of the market's overall value.
- In 2024, the Chinese biotechnology market recorded an annual growth of 7.5% due to advancements in genetic engineering and regulatory support.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in China
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in China
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the China biotechnology market with five year forecasts by both value and volume
- What was the size of the China biotechnology market by value in 2024?
- What will be the size of the China biotechnology market in 2029?
- What factors are affecting the strength of competition in the China biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in China's biotechnology market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Category segmentation
- 1.4. Geography segmentation
- 1.5. Market rivalry
- 1.6. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Category segmentation
- 4.2. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the key players?
- 7.2. What strategies do the key players follow?
- 7.3. What have been the most recent market developments?
- 8 Company Profiles
- 8.1. BeiGene Ltd
- 8.2. Innovent Biologics Inc
- 8.3. Sinovac Biotech Ltd
- 8.4. Novo Nordisk AS
- 8.5. BGI Genomics Co Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. About MarketLine
- List of Tables
- Table 1: China biotechnology industry value: $ million, 2019-24
- Table 2: China biotechnology industry category segmentation: % share, by value, 2019-24
- Table 3: China biotechnology industry category segmentation: $ million, 2019-24
- Table 4: China biotechnology industry geography segmentation: $ million, 2024
- Table 5: China biotechnology industry value forecast: $ million, 2024-29
- Table 6: BeiGene Ltd: Key Facts
- Table 7: BeiGene Ltd: Annual Financial Ratios
- Table 8: BeiGene Ltd: Key Employees
- Table 9: BeiGene Ltd: Key Employees Continued
- Table 10: Innovent Biologics Inc: Key Facts
- Table 11: Innovent Biologics Inc: Annual Financial Ratios
- Table 12: Innovent Biologics Inc: Key Employees
- Table 13: Sinovac Biotech Ltd: Key Facts
- Table 14: Sinovac Biotech Ltd: Annual Financial Ratios
- Table 15: Sinovac Biotech Ltd: Key Employees
- Table 16: Novo Nordisk AS: Key Facts
- Table 17: Novo Nordisk AS: Annual Financial Ratios
- Table 18: Novo Nordisk AS: Key Employees
- Table 19: BGI Genomics Co Ltd: Key Facts
- Table 20: BGI Genomics Co Ltd: Annual Financial Ratios
- Table 21: BGI Genomics Co Ltd: Key Employees
- Table 22: China Size of Population (Million), 2019-24
- Table 23: China Real GDP (Constant 2010 Prices, $ Billion), 2019-24
- Table 24: China GDP (Current Prices, $ Billion), 2019-24
- Table 25: China Inflation, 2019-24
- Table 26: China Consumer Price Index (Absolute), 2019-24
- Table 27: China Exchange Rate, 2019-24
- List of Figures
- Figure 1: China biotechnology industry value: $ million, 2019-24
- Figure 2: China biotechnology industry category segmentation: $ million, 2019-24
- Figure 3: China biotechnology industry geography segmentation: % share, by value, 2024
- Figure 4: China biotechnology industry value forecast: $ million, 2024-29
- Figure 5: Forces driving competition in the biotechnology industry in China, 2024
- Figure 6: Drivers of buyer power in the biotechnology industry in China, 2024
- Figure 7: Drivers of supplier power in the biotechnology industry in China, 2024
- Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in China, 2024
- Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in China, 2024
- Figure 10: Drivers of degree of rivalry in the biotechnology industry in China, 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook